ABCG8
Basic information
Region (hg38): 2:43831942-43882988
Links
Phenotypes
GenCC
Source:
- sitosterolemia (Definitive), mode of inheritance: AR
- sitosterolemia (Supportive), mode of inheritance: AR
- sitosterolemia 1 (Strong), mode of inheritance: AR
- sitosterolemia 1 (Definitive), mode of inheritance: AR
- sitosterolemia (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Sitosterolemia 1 | AR | Biochemical; Cardiovascular | In some individuals, medical (eg, with bile acid resins/lipid-lowering agents) and dietary (eg, with cholesterol and plant fat restriction) treatment may be beneficial for some parameters, and may, along with preventive measures related to cardiovascular manifestations, reduce morbidity and mortality | Biochemical; Cardiovascular; Hematologic | 11099417; 12840092; 16029460; 15996216; 31901240 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (21 variants)
- Sitosterolemia 1 (8 variants)
- Cardiovascular phenotype (3 variants)
- Abnormal circulating lipid concentration (1 variants)
- Hypercholesterolemia (1 variants)
- ABCG8-related disorder (1 variants)
- Sitosterolemia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ABCG8 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 123 | 135 | ||||
missense | 299 | 15 | 319 | |||
nonsense | 11 | 15 | ||||
start loss | 2 | |||||
frameshift | 11 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 14 | |||||
splice region | 13 | 10 | 4 | 27 | ||
non coding | 98 | 93 | 48 | 244 | ||
Total | 27 | 20 | 408 | 231 | 55 |
Highest pathogenic variant AF is 0.000256
Variants in ABCG8
This is a list of pathogenic ClinVar variants found in the ABCG8 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-43831944-C-A | Sitosterolemia | Uncertain significance (May 08, 2022) | ||
2-43831951-A-C | Cardiovascular phenotype | Uncertain significance (Aug 27, 2022) | ||
2-43831952-G-C | not specified | Uncertain significance (Aug 07, 2023) | ||
2-43831954-A-T | Cardiovascular phenotype | Uncertain significance (Apr 05, 2023) | ||
2-43831956-G-A | Cardiovascular phenotype | Likely benign (Oct 20, 2019) | ||
2-43831957-T-C | Sitosterolemia • Sitosterolemia 2 • ABCG5-related disorder • not specified | Uncertain significance (Aug 07, 2024) | ||
2-43831958-A-G | Sitosterolemia 2 | Uncertain significance (Feb 24, 2023) | ||
2-43831963-A-G | Cardiovascular phenotype | Uncertain significance (Aug 22, 2023) | ||
2-43831965-G-A | Sitosterolemia | Likely benign (Mar 19, 2023) | ||
2-43831966-C-A | Cardiovascular phenotype | Uncertain significance (Feb 10, 2023) | ||
2-43831966-C-G | Cardiovascular phenotype | Uncertain significance (Mar 16, 2023) | ||
2-43831972-T-C | Cardiovascular phenotype | Uncertain significance (May 07, 2023) | ||
2-43831982-C-A | Sitosterolemia | Pathogenic (Jun 09, 2023) | ||
2-43831983-C-G | Cardiovascular phenotype • Sitosterolemia • ABCG5-related disorder | Likely benign (May 19, 2022) | ||
2-43831984-C-T | ABCG5-related disorder | Uncertain significance (Sep 26, 2016) | ||
2-43831992-C-T | Sitosterolemia | Likely benign (Oct 26, 2022) | ||
2-43831994-C-CCCGG | Sitosterolemia 2 | Likely pathogenic (Jul 25, 2023) | ||
2-43831996-C-G | Cardiovascular phenotype | Uncertain significance (Sep 22, 2023) | ||
2-43832000-C-G | Cardiovascular phenotype | Uncertain significance (Apr 18, 2023) | ||
2-43832006-C-T | Sitosterolemia • not specified | Uncertain significance (Nov 27, 2023) | ||
2-43832007-A-G | Sitosterolemia | Likely benign (Jan 18, 2020) | ||
2-43832013-C-T | Sitosterolemia | Likely benign (Dec 11, 2022) | ||
2-43832013-C-CT | Cardiovascular phenotype | Pathogenic (Aug 24, 2023) | ||
2-43832016-C-T | Cardiovascular phenotype | Likely benign (Aug 19, 2019) | ||
2-43832018-C-A | Sitosterolemia | Uncertain significance (May 21, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ABCG8 | protein_coding | protein_coding | ENST00000272286 | 13 | 39503 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.38e-20 | 0.00188 | 125357 | 0 | 391 | 125748 | 0.00156 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -2.49 | 518 | 381 | 1.36 | 0.0000249 | 4386 |
Missense in Polyphen | 166 | 132.51 | 1.2527 | 1542 | ||
Synonymous | -2.20 | 202 | 166 | 1.22 | 0.0000122 | 1346 |
Loss of Function | -0.0337 | 30 | 29.8 | 1.01 | 0.00000159 | 338 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00320 | 0.00320 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000381 | 0.000381 |
Finnish | 0.00254 | 0.00254 |
European (Non-Finnish) | 0.00176 | 0.00176 |
Middle Eastern | 0.000381 | 0.000381 |
South Asian | 0.000719 | 0.000719 |
Other | 0.00163 | 0.00163 |
dbNSFP
Source:
- Function
- FUNCTION: ABCG5 and ABCG8 form an obligate heterodimer that mediates Mg(2+)- and ATP-dependent sterol transport across the cell membrane. Plays an essential role in the selective transport of the dietary cholesterol in and out of the enterocytes and in the selective sterol excretion by the liver into bile (PubMed:11099417, PubMed:11452359, PubMed:27144356, PubMed:15054092). Required for normal sterol homeostasis (PubMed:11099417, PubMed:11452359, PubMed:15054092). The heterodimer with ABCG5 has ATPase activity (PubMed:16893193, PubMed:20210363, PubMed:27144356). {ECO:0000269|PubMed:11099417, ECO:0000269|PubMed:11452359, ECO:0000269|PubMed:15054092, ECO:0000269|PubMed:16893193, ECO:0000269|PubMed:27144356}.;
- Disease
- DISEASE: Gallbladder disease 4 (GBD4) [MIM:611465]: One of the major digestive diseases. Gallstones composed of cholesterol (cholelithiasis) are the common manifestations in western countries. Most people with gallstones, however, remain asymptomatic through their lifetimes. {ECO:0000269|PubMed:17632509}. Note=Disease susceptibility may be associated with variations affecting the gene represented in this entry.; DISEASE: Sitosterolemia (STSL) [MIM:210250]: Rare autosomal recessive disorder characterized by increased intestinal absorption of all sterols including cholesterol, plant and shellfish sterols, and decreased biliary excretion of dietary sterols into bile. Sitosterolemia patients have hypercholesterolemia, very high levels of plant sterols in the plasma, and frequently develop tendon and tuberous xanthomas, accelerated atherosclerosis and premature coronary artery disease. {ECO:0000269|PubMed:11099417, ECO:0000269|PubMed:11452359, ECO:0000269|PubMed:15054092}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Fat digestion and absorption - Homo sapiens (human);Bile secretion - Homo sapiens (human);ABC transporters - Homo sapiens (human);Cholesterol metabolism - Homo sapiens (human);Statin Pathway, Pharmacodynamics;Liver X Receptor Pathway;Nuclear Receptors Meta-Pathway;Angiopoietin Like Protein 8 Regulatory Pathway;Liver steatosis AOP;Statin Pathway;Vitamin A and Carotenoid Metabolism;ABC transporters in lipid homeostasis;Transport of small molecules;C21-steroid hormone biosynthesis and metabolism;ABC-family proteins mediated transport
(Consensus)
Recessive Scores
- pRec
- 0.333
Intolerance Scores
- loftool
- 0.275
- rvis_EVS
- 0.74
- rvis_percentile_EVS
- 86.38
Haploinsufficiency Scores
- pHI
- 0.138
- hipred
- N
- hipred_score
- 0.251
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.676
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Abcg8
- Phenotype
- liver/biliary system phenotype; digestive/alimentary phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- drug transmembrane transport;response to nutrient;excretion;negative regulation of intestinal phytosterol absorption;phospholipid transport;intestinal cholesterol absorption;cholesterol efflux;cholesterol homeostasis;negative regulation of intestinal cholesterol absorption;transmembrane transport
- Cellular component
- plasma membrane;integral component of plasma membrane;apical plasma membrane;ATP-binding cassette (ABC) transporter complex;receptor complex
- Molecular function
- protein binding;ATP binding;ATPase activity;cholesterol transporter activity;ATPase activity, coupled to transmembrane movement of substances;metal ion binding;protein heterodimerization activity